tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cobram Estate Olives Flags Lapse of Options and Performance Rights

Story Highlights
  • Cobram Estate Olives cancelled 1.2 million options and 30,000 performance rights.
  • Lapsed incentives slightly reduce potential future dilution without materially changing capital.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Cobram Estate Olives Flags Lapse of Options and Performance Rights

Claim 70% Off TipRanks Premium

Cobram Estate Olives Ltd. ( (AU:CBO) ) just unveiled an update.

Cobram Estate Olives Limited has notified the ASX of the cessation of certain securities, including 1.2 million options expiring in April 2028 and 30,000 performance rights expiring in September 2027, after the conditions attached to these instruments were not met or became incapable of being satisfied. The lapse of these conditional rights slightly reduces the company’s pool of potential equity issuance under these incentive instruments, which may modestly affect future dilution but does not alter its current issued capital structure materially.

The most recent analyst rating on (AU:CBO) stock is a Buy with a A$3.65 price target. To see the full list of analyst forecasts on Cobram Estate Olives Ltd. stock, see the AU:CBO Stock Forecast page.

More about Cobram Estate Olives Ltd.

Cobram Estate Olives Limited is an Australian-listed agribusiness that operates in the olive oil industry, producing and marketing olive oil and related products. The company is listed on the ASX under the code CBO and manages its capital structure through various equity and performance-based securities.

Average Trading Volume: 548,228

Technical Sentiment Signal: Buy

Current Market Cap: A$1.87B

See more data about CBO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1